跳至主要内容
临床试验/NCT04907838
NCT04907838Unknown不适用

Insulin Stimulated Vasodilation in Patients With Type 2 Diabetes

University of Southern Denmark1 个研究点 分布在 1 个国家目标入组 22 人开始时间: 2018年5月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
22
试验地点
1
主要终点
Glucose infusion rate

研究概览

简要总结

This study evaluates the role of endothelin in insulin stimulated vasodilation and glucose uptake. The subjects will complete an hyperinsulinemic euglycemic clamp with and without blockade of the endothelin receptors.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
40 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Type 2 diabetes OR healthy control (no type 2 diabetes)

排除标准

  • heart disease
  • pregnancy or birth within 3 month
  • Kidney disease
  • beta-blockers
  • insulin treatment (for type 2 diabetics)

研究组 & 干预措施

Healthy controls

Experimental

BQ123 (25 nmol/min), BQ788 (25 nmol/min)

干预措施: Insulin clamp (Drug)

Type 2 diabetics

Experimental

BQ123 (25 nmol/min), BQ788 (25 nmol/min)

干预措施: BQ123 + BQ788 (Drug)

Type 2 diabetics

Experimental

BQ123 (25 nmol/min), BQ788 (25 nmol/min)

干预措施: Insulin clamp (Drug)

Type 2 diabetics

Experimental

BQ123 (25 nmol/min), BQ788 (25 nmol/min)

干预措施: BQ123 (Drug)

Healthy controls

Experimental

BQ123 (25 nmol/min), BQ788 (25 nmol/min)

干预措施: BQ123 (Drug)

Healthy controls

Experimental

BQ123 (25 nmol/min), BQ788 (25 nmol/min)

干预措施: BQ123 + BQ788 (Drug)

结局指标

主要结局

Glucose infusion rate

时间窗: 3.5 hours

Glucose infusion rate required to maintain euglycemia during insulin clamp with and without endothelin blockade

Leg blood flow

时间窗: 3.5 hours

Effect of endothelin receptor blockade on leg blood flow (ultrasound Doppler) during insulin clamp with and without endothelin blockade

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Stefan Mortensen

Professor

University of Southern Denmark

研究点 (1)

Loading locations...

相似试验